As previously reported, Wells Fargo analyst Stephen Baxter downgraded Cigna to Equal Weight from Overweight with a price target of $355, down from $370. While the analyst thinks the company’s fundamentals remain solid, he believes the tailwinds are generally well-understood, and sees limited potential for additional multiple expansion following significant outperformance in 2022.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CI:
- Walmart to pay $500,000 over workers’ compensation prescription procedures
- Managed care company returns will be tough to keep replicating, WSJ says
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- Cigna price target raised to $344 from $294 at RBC Capital
- Cigna price target raised to $385 from $329 at Cowen